Telemonitoring for patients with COPD
Evaluation of the Usefulness and Efficacy of Telemonitoring of Patients With COPD
This study is testing if using telemonitoring can help adults with COPD manage their condition better and reduce hospital visits after a flare-up.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 164 (estimated) |
| Ages | 18 Years to 90 Years |
| Sex | All |
| Sponsor | University of Monastir Academic / other |
| Locations | 1 site (Monastir) |
| Trial ID | NCT06135025 on ClinicalTrials.gov |
What this trial studies
This study evaluates the effectiveness of telemonitoring in managing patients with chronic obstructive pulmonary disease (COPD) who have recently experienced an exacerbation. By utilizing telehealth, the study aims to enhance clinical management, improve access to healthcare, and support self-management among these patients. The research focuses on assessing whether telemonitoring can reduce the frequency of exacerbations, improve quality of life, and decrease hospitalization rates. The study includes adult patients diagnosed with COPD according to GOLD criteria and excludes those with certain conditions that may interfere with the study's outcomes.
Who should consider this trial
Good fit: Ideal candidates are adults over 18 years old with a prior diagnosis of COPD.
Not a fit: Patients with dementia, pregnancy, or those unable to engage in the study may not benefit from this intervention.
Why it matters
Potential benefit: If successful, this approach could lead to better management of COPD, reducing exacerbations and hospitalizations for patients.
How similar studies have performed: Other studies have shown promising results with telehealth approaches for managing chronic conditions, suggesting potential success for this method in COPD management.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients aged over 18 years old with prior diagnosis of COPD according to GOLD criteria Exclusion Criteria: * dementia * pregnancy * reluctance or self-declared inability to engage in the study * simultaneous participation in another trial involving a therapeutic or non-therapeutic intervention that will interfere with the primary and secondary endpoints of this study.
Where this trial is running
Monastir
- Khaoula Bel Haj Ali — Monastir, Tunisia (Recruiting)
Study contacts
- Study coordinator: Khaoula Bel Haj Ali, MD
- Email: belhajalikhaoula@yahoo.fr
- Phone: 73106000
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.